GlassScriptPhysician profile
Rina K Patel
NPI 1407086127
$24,900.10
in general payments reported to CMS, 2019-2025
90 companies · $5,688 in 2025
The $5,688 reported for 2025 was more than what 75% of Medical Oncology providers received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $773 · 2020: $2,202 · 2021: $2,633 · 2022: $3,548 · 2023: $4,712 · 2024: $5,342 · 2025: $5,688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Long Term Medical Supply Or Device Loan: $698 · Education: $36.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,008.51 |
| Long Term Medical Supply Or Device Loan | $697.90 |
| Education | $36.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,103.51 | 2019-2025 | Piqray, Kisqali |
| Pfizer INC. | $1,488.87 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,429.64 | 2019-2025 | Enhertu, Tagrisso, Bevespi Aerosphere |
| Celgene Corporation | $1,367.95 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Janssen Biotech, INC. | $1,234.14 | 2020-2025 | Erleada, Rybrevant, Carvykti |
| Daiichi Sankyo INC. | $1,117.74 | 2020-2025 | Enhertu, Datroway |
| Genzyme Corporation | $968.12 | 2020-2025 | |
| Glaxosmithkline, LLC. | $854.50 | 2019-2025 | Zejula, Jemperli, Ojjaara |
| Seagen INC. | $812.48 | 2019-2023 | Adcetris, Padcev, Tukysa |
| E.R. Squibb & Sons, L.L.C. | $808.94 | 2019-2025 | Opdivo, Opdualag |
| Merck Sharp & Dohme LLC | $796.11 | 2019-2024 | Keytruda, Lynparza, Welireg |
| Incyte Corporation | $746.04 | 2020-2025 | Jakafi, Monjuvi, Pemazyre |
| Bayer Healthcare Pharmaceuticals INC. | $698.19 | 2019-2025 | |
| Astellas Pharma US INC | $623.19 | 2019-2025 | Xtandi, Padcev, Vyloy |
| Lilly USA, LLC | $532.35 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
Show all 90 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $501.14 | 2019-2025 | Fruzaqla, Ninlaro, Vonvendi |
| Eisai INC. | $497.58 | 2020-2025 | |
| Abbvie INC. | $497.50 | 2019-2025 | |
| Sobi, INC | $469.18 | 2022-2025 | |
| Alexion Pharmaceuticals, INC. | $434.16 | 2019-2025 | Ultomiris |
| Array Biopharma INC | $320.64 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Tersera Therapeutics LLC | $316.33 | 2022-2025 | Zoladex |
| Amgen INC. | $313.15 | 2019-2022 | |
| Puma Biotechnology, INC. | $285.32 | 2020-2025 | |
| Ipsen Biopharmaceuticals, INC | $285.20 | 2019-2025 | Onivyde, Tazverik, Somatuline Depot |
| Genentech USA, INC. | $274.74 | 2022-2025 | Polivy, Itovebi, Venclexta |
| Pharmaessentia USA Corporation | $256.50 | 2022-2025 | Besremi |
| Beigene USA, INC. | $252.30 | 2021-2025 | Brukinsa, Tevimbra |
| Pharmacyclics LLC, An Abbvie Company | $251.19 | 2020-2023 | Imbruvica, Epkinly |
| Boehringer Ingelheim Pharmaceuticals, INC. | $233.97 | 2019-2025 | |
| Tg Therapeutics, INC. | $233.28 | 2021 | |
| Jazz Pharmaceuticals INC. | $228.79 | 2020-2025 | |
| Emd Serono, INC. | $228.09 | 2022-2025 | Bavencio, Tepmetko |
| Rigel Pharmaceuticals, INC. | $201.89 | 2023-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Deciphera Pharmaceuticals INC. | $194.04 | 2021-2025 | Qinlock, Romvimza, Tgct |
| Stemline Therapeutics INC. | $183.42 | 2023-2025 | Orserdu |
| Servier Pharmaceuticals LLC | $178.35 | 2022-2024 | |
| Kyowa Kirin, INC. | $150.42 | 2020-2024 | Poteligeo |
| Adaptive Biotechnologies Corporation | $149.09 | 2022-2025 | Clonoseq |
| Taiho Oncology, INC. | $126.66 | 2020-2025 | |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Legend Biotech USA INC. | $117.03 | 2024-2025 | Carvykti |
| Regeneron Healthcare Solutions, INC. | $104.15 | 2023-2025 | Libtayo |
| Dova Pharmaceuticals | $102.23 | 2019-2021 | |
| La Jolla Pharmaceutical Company | $97.88 | 2021 | |
| Clovis Oncology, INC. | $91.72 | 2020-2021 | |
| Recordati_rare_diseases_inc. | $89.32 | 2023-2025 | Sylvant, Enjaymo, Panhematin |
| Global Blood Therapeutics, INC. | $88.68 | 2020-2022 | |
| Aveo Pharmaceuticals, INC. | $80.87 | 2022-2023 | Fotivda |
| Pharmacosmos Therapeutics INC. | $73.06 | 2024 | Monoferric, Cosela |
| Myriad Genetic Laboratories, INC. | $71.56 | 2021-2023 | Precisetumor |
| Sun Pharmaceutical Industries INC. | $70.37 | 2022 | |
| Agios Pharmaceuticals, INC. | $67.84 | 2023-2025 | Pyrukynd |
| Geron Corporation | $62.05 | 2025 | Rytelo |
| Exelixis INC. | $61.06 | 2019-2020 | |
| Octapharma USA, INC. | $59.18 | 2020 | |
| Acrotech Biopharma INC. | $58.82 | 2022-2024 | Beleodaq |
| Ge Healthcare | $57.16 | 2022-2025 | |
| Acceleron Pharma, INC. | $49.94 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $46.88 | 2022-2023 | Givlaari |
| Coherus Oncology, INC. | $38.85 | 2023 | |
| Eusa Pharma (US) LLC | $36.65 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $35.99 | 2024-2025 | Sancuso |
| Morphosys, US INC. | $35.20 | 2021 | |
| Cti Biopharma Corp. | $35.10 | 2022-2023 | Vonjo |
| Gilead Sciences, INC. | $34.40 | 2025 | Trodelvy |
| Heron Therapeutics, INC. | $31.02 | 2020-2021 | |
| Aurobindo Pharma USA, INC. | $30.46 | 2019-2020 | |
| Spectrum Pharmaceuticals INC. | $29.17 | 2019 | |
| Foundation Medicine, INC. | $28.99 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $28.73 | 2024 | Orgovyx |
| Azurity Pharmaceuticals, INC. | $24.83 | 2025 | Danziten |
| Iovance Biotherapeutics, INC. | $24.63 | 2025 | Amtagvi |
| Dendreon Pharmaceuticals LLC | $23.30 | 2024 | Provenge |
| Mirati Therapeutics, INC. | $22.08 | 2023 | Krazati |
| Ferring Pharmaceuticals INC. | $21.92 | 2020 | |
| Springworks Therapeutics, INC. | $21.70 | 2024 | Ogsiveo |
| Fennec Pharmaceuticals, INC. | $18.81 | 2025 | Fyarro |
| Immunogen, INC. | $18.36 | 2023 | Elahere |
| Beone Medicines USA, INC. | $18.11 | 2025 | Brukinsa |
| Adc Therapeutics America, INC. | $17.82 | 2025 | |
| Secura Bio, INC. | $16.48 | 2019-2020 | |
| Novocure INC. | $14.68 | 2025 | Optune Lua (Novottf-200t) |
| Napo Pharmaceuticals INC | $14.31 | 2025 | Gelclair Concentrated Oral Gel |
| Menarini Silicon Biosystems, INC. | $14.04 | 2025 | |
| Kite Pharma, INC. | $13.36 | 2021 | |
| Fortovia Therapeutics, INC. | $12.98 | 2020 | |
| Sirtex Medical INC | $9.65 | 2020 | |
| Organon LLC | $7.06 | 2023 | Ontruzant |
| Veracyte, INC. | $1.92 | 2020 |
Drugs and devices associated with these payments
Kisqali $1,257Enhertu $1,019Keytruda $562Reblozyl $560Erleada $408Vonjo $359Venclexta $356Jakafi $351Jaypirca $350Zejula $318Jemperli $313Sarclisa $301Nubeqa $301Tukysa $299Ojjaara $297Adcetris $294Pluvicto $281Verzenio $273Padcev $266Rybrevant $265Lenvima $265Ultomiris $262Zoladex $261Ibrance $248Tagrisso $243Braftovi $242Opdivo $236Lynparza $233Piqray $233Carvykti $220Xofigo $219Opdualag $212Rezlidhia $202Tavalisse $202Mektovi $201Pomalyst $198Vitrakvi $196Stivarga $196Lutathera $195Zepzelca $193Xtandi $192Imbruvica $190Tivdak $190Elrexfio $183Orserdu $183Besremi $162Lorbrena $148Welireg $148Brukinsa $147Akeega $128Voquezna $125Clonoseq $121Orgovyx $120Bosulif $114Fruzaqla $112Enjaymo $111Cablivi $108Datroway $107Libtayo $104Doptelet $99.15Epkinly $98.97Retevmo $95.66Tibsovo $95.33Qinlock $83.67Monjuvi $80.77Oxbryta $76.50Talzenna $76.29Bevespi Aerosphere $75.17Ninlaro $74.49Vyloy $73.09Onivyde $71.95Vonvendi $70.49Balversa $69.06Pyrukynd $67.84Gavreto $64.26Xospata $63.22Iclusig $62.91Rytelo $62.05Elahere $58.31Inlyta $55.55Inqovi $54.75Lonsurf $54.75Polivy $52.93Jevtana $52.05Tevimbra $49.05Idhifa $48.32Fotivda $46.79Scemblix $45.62Itovebi $45.34Sylvant $43.86Elitek $43.14Shingrix $42.13Pemazyre $40.90Bavencio $40.00Zynyz $39.87Poteligeo $39.63Tazverik $39.31Udenyca $38.85Monoferric $38.63Xalkori $37.68
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rina Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.